Live Breaking News & Updates on Sternir Inc

Stay updated with breaking news from Sternir inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Inhibikase Therapeutics Reports First Quarter Financial Results and Highlights Recent Period Activity

Company to host conference call on Thursday, May 16, 2024 at 8:00 a.m. ETBOSTON and ATLANTA, May 15, 2024 Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing. ....

United States , Alex Lobo , Miltonh Werner , Office Of Cardiology , Division Of Cardiology , Sternir Inc , Company Contact , Steam Review , Exchange Commission , Inhibikase Or Company , Division Of Hematologic Malignancies , Inhibikase Therapeutics Inc , Abelson Tyrosine Kinases , Chief Executive Officer , Upcoming Milestones , Meeting Minutes , Hematologic Malignancies , Review Team , Pulmonary Arterial Hypertension , Final Meeting Minutes , Abelson Tyrosine Kinase , Abelson Tyrosine , Multiple System Atrophy , Private Securities Litigation Reform Act , Consolidated Statements , Comprehensive Loss ,

Inhibikase Therapeutics Reports First Quarter Financial

Company to host conference call on Thursday, May 16, 2024 at 8:00 a.m. ET. ....

United States , Miltonh Werner , Alex Lobo , Inhibikase Therapeutics Inc , Division Of Hematologic Malignancies , Inhibikase Or Company , Exchange Commission , Steam Review , Company Contact , Division Of Cardiology , Sternir Inc , Office Of Cardiology , Abelson Tyrosine Kinases , Chief Executive Officer , Upcoming Milestones , Meeting Minutes , Hematologic Malignancies , Review Team , Pulmonary Arterial Hypertension , Final Meeting Minutes , Abelson Tyrosine Kinase , Abelson Tyrosine , Multiple System Atrophy , Private Securities Litigation Reform Act , Consolidated Statements , Comprehensive Loss ,

Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs

BOSTON and ATLANTA, April 18, 2024 Inhibikase Therapeutics, Inc. , a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson s. ....

United States , Miltonh Werner , Alex Lobo , Inhibikase Or Company , Sternir Inc , Exchange Commission , Institute Of The National Institutes Health , National Institute Of Neurological Disease , Company Contact , Drug Administration For Ik , Inhibikase Therapeutics Inc , Abelson Tyrosine Kinases , Fellow Shareholders , Inhibikase Therapeutics , Drug Administration , Multiple System Atrophy , National Institute , Neurological Disease , National Institutes , Pulmonary Arterial Hypertension , Abelson Tyrosine Kinase , Abelson Tyrosine , Private Securities Litigation Reform Act ,

Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs

Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , Miltonh Werner , Alex Lobo , Company Contact , Inhibikase Therapeutics Inc , Institute Of The National Institutes Health , Inhibikase Or Company , National Institute Of Neurological Disease , Sternir Inc , Drug Administration For Ik , Development Programs , Exchange Commission , Therapeutics Issues Letter , Provides Update , Abelson Tyrosine Kinases , Fellow Shareholders , Inhibikase Therapeutics , Drug Administration , Multiple System Atrophy , National Institute , Neurological Disease , National Institutes , Pulmonary Arterial Hypertension , Abelson Tyrosine Kinase , Abelson Tyrosine , Private Securities Litigation Reform Act ,

Inhibikase Therapeutics Issues Letter to Shareholders and Provides Update on Development Programs

BOSTON and ATLANTA, Dec. 19, 2023 (GLOBE NEWSWIRE) Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage phar. ....

United States , Alex Lobo , Miltonh Werner , Company Contact , Inhibikase Therapeutics Inc , Inhibikase Or Company , European Union , Sternir Inc , Exchange Commission , Abelson Tyrosine Kinases , Fellow Shareholders , Inhibikase Therapeutics , Multiple System Atrophy , Orphan Drug Designation , Abelson Tyrosine Kinase , Ableson Tyrosine , Private Securities Litigation Reform Act ,